Allowed Publications
Cutis
Dermatology News
Emergency Medicine
Cardiology News
Neurology Reviews
Clinical Neurology News
Internal Medicine News
Infectious Disease Practitioner
The Journal of Family Practice
Family Practice News
Rheumatology News
Clinical Endocrinology News
Oncology Practice
The Journal of Community and Supportive Oncology
Hematology News
ACS Surgery News
The American Journal of Orthopedics
Pediatric News
Ob.Gyn. News
OBG Management
Multiple Sclerosis Hub
The Hospitalist
Thoracic Surgery News (Archived)
Vascular Specialist
Clinical Psychiatry News
Current Psychiatry
Anticoagulation Hub
Diabetes Hub
AVAHO
CHEST Physician
Cleveland Clinic Journal of Medicine
Clinician Reviews
Epilepsy Resource Center
Federal Practitioner
GI and Hepatology News
HCV Hub
Medscape Content Type
10001

Barry Singer, MD

Article Type
Video
Changed
Display Headline
Barry Singer, MD

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

Author and Disclosure Information

Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Topics
Multiple Sclerosis
Legacy Keywords
MS, Barry Singer, Neurology Reviews
Author and Disclosure Information

Author and Disclosure Information

Related Articles
Global Survey Uncovers the Often Unspoken Challenges of MS

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

References

Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Topics
Multiple Sclerosis
Article Type
Video
Display Headline
Barry Singer, MD
Display Headline
Barry Singer, MD
Legacy Keywords
MS, Barry Singer, Neurology Reviews
Legacy Keywords
MS, Barry Singer, Neurology Reviews
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Stacey Cofield, PhD, of NARCOMS

Article Type
Video
Changed
Display Headline
Stacey Cofield, PhD, of NARCOMS

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

Author and Disclosure Information

Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Topics
Multiple Sclerosis
Legacy Keywords
marijuana, NARCOMS, Stacey Cofield, Neurology Reviews, spasticity, attitude
Author and Disclosure Information

Author and Disclosure Information

Related Articles
Do Attitudes Toward Marijuana Differ Between Men and Women With MS?

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

References

Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Publications
Neurology Reviews
Multiple Sclerosis Hub
MDedge Neurology
ICYMI Multiple Sclerosis
Topics
Multiple Sclerosis
Article Type
Video
Display Headline
Stacey Cofield, PhD, of NARCOMS
Display Headline
Stacey Cofield, PhD, of NARCOMS
Legacy Keywords
marijuana, NARCOMS, Stacey Cofield, Neurology Reviews, spasticity, attitude
Legacy Keywords
marijuana, NARCOMS, Stacey Cofield, Neurology Reviews, spasticity, attitude
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Depression and Diabetes

Article Type
Video
Changed
Display Headline
Depression and Diabetes
Author(s)
Ellen D. Mandel, DMH, MPA, MS, PA-C
Rdn, CDE

Ellen D. Mandel discusses the surprising reason to screen for depression among patients with diabetes. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Covered the incidence and screening for depression among diabetic patients.
  2. Discussed causes of depression in diabetes: role of both the patient and provider.
  3. Reviewed strategies to assess and manage depression.
  4. Listed indications for referral to a mental health provider.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Ellen D. Mandel will continue to delve into the relationship between depression and chronic disease at the upcoming 2016 MEDS conference. Click here to learn more.

References

Author and Disclosure Information

Ellen D. Mandel, DMH, MPA, MS, PA-C, RDN, CDE

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Mental Health
Endocrinology
Author(s)
Ellen D. Mandel, DMH, MPA, MS, PA-C
Rdn, CDE
Author(s)
Ellen D. Mandel, DMH, MPA, MS, PA-C
Rdn, CDE
Author and Disclosure Information

Ellen D. Mandel, DMH, MPA, MS, PA-C, RDN, CDE

Author and Disclosure Information

Ellen D. Mandel, DMH, MPA, MS, PA-C, RDN, CDE

Ellen D. Mandel discusses the surprising reason to screen for depression among patients with diabetes. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Covered the incidence and screening for depression among diabetic patients.
  2. Discussed causes of depression in diabetes: role of both the patient and provider.
  3. Reviewed strategies to assess and manage depression.
  4. Listed indications for referral to a mental health provider.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Ellen D. Mandel will continue to delve into the relationship between depression and chronic disease at the upcoming 2016 MEDS conference. Click here to learn more.

Ellen D. Mandel discusses the surprising reason to screen for depression among patients with diabetes. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Covered the incidence and screening for depression among diabetic patients.
  2. Discussed causes of depression in diabetes: role of both the patient and provider.
  3. Reviewed strategies to assess and manage depression.
  4. Listed indications for referral to a mental health provider.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Ellen D. Mandel will continue to delve into the relationship between depression and chronic disease at the upcoming 2016 MEDS conference. Click here to learn more.

References

References

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Mental Health
Endocrinology
Article Type
Video
Display Headline
Depression and Diabetes
Display Headline
Depression and Diabetes
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Triglycerides and Cardiovascular Risk

Article Type
Video
Changed
Display Headline
Triglycerides and Cardiovascular Risk
Author(s)
Joyce Ross, MSN, RNC, CPNP, CS, FNLA

Joyce Ross explains the role of triglycerides in cardiovascular health and how to manage high levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Triglycerides on the Rise: Confronting Residual Cardiometabolic Risk,” co-presented with Gregory S. Pokrywka, MD, CACP, FNLA, NCMP, jointly provided by Postgraduate Institute for Medicine and Medtelligence, and supported by an educational grant from Amarin Pharma Inc.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

Author and Disclosure Information

Joyce Ross, MSN, RNC, CPNP, CS, FNLA

Publications
Clinician Reviews
Pulmonary Health Hub
Topics
Cardiology
Pulmonology
Endocrinology
Sections
Articles
Author(s)
Joyce Ross, MSN, RNC, CPNP, CS, FNLA
Author(s)
Joyce Ross, MSN, RNC, CPNP, CS, FNLA
Author and Disclosure Information

Joyce Ross, MSN, RNC, CPNP, CS, FNLA

Author and Disclosure Information

Joyce Ross, MSN, RNC, CPNP, CS, FNLA

Joyce Ross explains the role of triglycerides in cardiovascular health and how to manage high levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Triglycerides on the Rise: Confronting Residual Cardiometabolic Risk,” co-presented with Gregory S. Pokrywka, MD, CACP, FNLA, NCMP, jointly provided by Postgraduate Institute for Medicine and Medtelligence, and supported by an educational grant from Amarin Pharma Inc.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Joyce Ross explains the role of triglycerides in cardiovascular health and how to manage high levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Triglycerides on the Rise: Confronting Residual Cardiometabolic Risk,” co-presented with Gregory S. Pokrywka, MD, CACP, FNLA, NCMP, jointly provided by Postgraduate Institute for Medicine and Medtelligence, and supported by an educational grant from Amarin Pharma Inc.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

References

Publications
Clinician Reviews
Pulmonary Health Hub
Publications
Clinician Reviews
Pulmonary Health Hub
Topics
Cardiology
Pulmonology
Endocrinology
Article Type
Video
Display Headline
Triglycerides and Cardiovascular Risk
Display Headline
Triglycerides and Cardiovascular Risk
Sections
Articles
Article Source

PURLs Copyright

Inside the Article

Teaser Media

The Role of the Kidney in Glycemic Control

Article Type
Video
Changed
Display Headline
The Role of the Kidney in Glycemic Control
Author(s)
Ji Hyun (Cj) Chun, MPAS, PA-C

Ji Hyun (CJ) Chun highlights the reasons for targeting the kidney for lowering blood glucose levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Looking Beyond Insulin-Based Therapies in Type 2 Diabetes: The Role of the Kidney in Glycemic Control,” co-presented by Mary D. Knudtson, DNSc, FNP/PNP-BC, FAAN and Creative Educational Concepts, Inc., and supported by an independent educational grant from AstraZeneca.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

Author and Disclosure Information

Ji Hyun (CJ) Chun, MPAS, PA-C

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Nephrology
Endocrinology
Author(s)
Ji Hyun (Cj) Chun, MPAS, PA-C
Author(s)
Ji Hyun (Cj) Chun, MPAS, PA-C
Author and Disclosure Information

Ji Hyun (CJ) Chun, MPAS, PA-C

Author and Disclosure Information

Ji Hyun (CJ) Chun, MPAS, PA-C

Ji Hyun (CJ) Chun highlights the reasons for targeting the kidney for lowering blood glucose levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Looking Beyond Insulin-Based Therapies in Type 2 Diabetes: The Role of the Kidney in Glycemic Control,” co-presented by Mary D. Knudtson, DNSc, FNP/PNP-BC, FAAN and Creative Educational Concepts, Inc., and supported by an independent educational grant from AstraZeneca.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Ji Hyun (CJ) Chun highlights the reasons for targeting the kidney for lowering blood glucose levels.

This video provides three takeaways in less than three minutes from the presentation at the 2015 MEDS conference, entitled “Looking Beyond Insulin-Based Therapies in Type 2 Diabetes: The Role of the Kidney in Glycemic Control,” co-presented by Mary D. Knudtson, DNSc, FNP/PNP-BC, FAAN and Creative Educational Concepts, Inc., and supported by an independent educational grant from AstraZeneca.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

References

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Nephrology
Endocrinology
Article Type
Video
Display Headline
The Role of the Kidney in Glycemic Control
Display Headline
The Role of the Kidney in Glycemic Control
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Interpreting Thyroid Labs

Article Type
Video
Changed
Display Headline
Interpreting Thyroid Labs
Author(s)
Christopher E. Sadler, MA, PA-C, CDE

Christopher E. Sadler describes the two biggest mistakes in evaluating TSH lab values. This video provides three takeaways in less than three minutes from his presentation at the 2015 MEDS conference, which

  1. Reviewed appropriate laboratory evaluation and interpretation for thyroid disease.
  2. Described the diagnostic work-up for hyperthyroidism.
  3. Interpreted laboratory, ultrasound and thyroid scan data in the diagnosis of hyperthyroidism.
  4. Provided an understanding of the benefits and risks of the different treatment options for hyperthyroidism.

Join Chris Sadler and other endocrine experts at the upcoming 2016 MEDS conference. Click here to learn more.

Author and Disclosure Information

Christopher E. Sadler, MA, PA-C, CDE

Publications
Clinician Reviews
Topics
Endocrinology
Author(s)
Christopher E. Sadler, MA, PA-C, CDE
Author(s)
Christopher E. Sadler, MA, PA-C, CDE
Author and Disclosure Information

Christopher E. Sadler, MA, PA-C, CDE

Author and Disclosure Information

Christopher E. Sadler, MA, PA-C, CDE

Christopher E. Sadler describes the two biggest mistakes in evaluating TSH lab values. This video provides three takeaways in less than three minutes from his presentation at the 2015 MEDS conference, which

  1. Reviewed appropriate laboratory evaluation and interpretation for thyroid disease.
  2. Described the diagnostic work-up for hyperthyroidism.
  3. Interpreted laboratory, ultrasound and thyroid scan data in the diagnosis of hyperthyroidism.
  4. Provided an understanding of the benefits and risks of the different treatment options for hyperthyroidism.

Join Chris Sadler and other endocrine experts at the upcoming 2016 MEDS conference. Click here to learn more.

Christopher E. Sadler describes the two biggest mistakes in evaluating TSH lab values. This video provides three takeaways in less than three minutes from his presentation at the 2015 MEDS conference, which

  1. Reviewed appropriate laboratory evaluation and interpretation for thyroid disease.
  2. Described the diagnostic work-up for hyperthyroidism.
  3. Interpreted laboratory, ultrasound and thyroid scan data in the diagnosis of hyperthyroidism.
  4. Provided an understanding of the benefits and risks of the different treatment options for hyperthyroidism.

Join Chris Sadler and other endocrine experts at the upcoming 2016 MEDS conference. Click here to learn more.

Publications
Clinician Reviews
Publications
Clinician Reviews
Topics
Endocrinology
Article Type
Video
Display Headline
Interpreting Thyroid Labs
Display Headline
Interpreting Thyroid Labs
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Teaser Media

Case Studies in Type 2 Diabetes: Which Agents and Why

Article Type
Video
Changed
Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
Author(s)
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA

Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which

  1. Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
  2. Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
  3. Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
  4. Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.

References

Author and Disclosure Information

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Endocrinology
Author(s)
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA
Author(s)
Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA
Author and Disclosure Information

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA

Author and Disclosure Information

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
B. Scott Urquhart, PA-C, DFAAPA

Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which

  1. Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
  2. Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
  3. Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
  4. Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.

Lucia M. Novak and B. Scott Urquhart describe the parameters for glucose lowering, using glucose- and patient-centric approaches for achieving the target A1C. This video provides three takeaways in less than three minutes from their presentation at the 2015 MEDS conference, which

  1. Reviewed the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.
  2. Critiqued the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.
  3. Applied a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.
  4. Demonstrated how a patient-centric approach promotes empowerment and positive outcomes.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Explore intriguing new cases in type 2 diabetes with endocrine experts Lucia Novak and Scott Urquhart at the upcoming 2016 MEDS conference. Click here to learn more.

References

References

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Endocrinology
Article Type
Video
Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
Display Headline
Case Studies in Type 2 Diabetes: Which Agents and Why
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Renal Medication Dosing: "The Good, the Bad and the Iatrogenic"

Article Type
Video
Changed
Display Headline
Renal Medication Dosing: "The Good, the Bad and the Iatrogenic"
Author(s)
Kim Zuber
Pac, DFAAPA
Fnkf

Kim Zuber offers insight into the iatrogenic causes of acute kidney injury. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Reviewed common medications taken by CKD patients, by CKD stage.
  2. Reviewed common dosing errors and the pathological rationale for medication selection, by CKD stage.
  3. Used patient examples, discusses medication dosing errors that are commonly found for the CKD patient.
  4. Provided a quick overview of the OTC meds dangerous for the CKD patient.
  5. Highlighted AKI on CKD for the non-nephrology practitioner.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Don’t miss Kim Zuber sharing her expertise on renal medication dosing as well as CKD and the diabetic kidney at the upcoming 2016 MEDS conference. Click here to learn more.

References

Author and Disclosure Information

Kim Zuber, PAC, DFAAPA, FNKF

Publications
Clinician Reviews
Topics
Nephrology
Endocrinology
Author(s)
Kim Zuber
Pac, DFAAPA
Fnkf
Author(s)
Kim Zuber
Pac, DFAAPA
Fnkf
Author and Disclosure Information

Kim Zuber, PAC, DFAAPA, FNKF

Author and Disclosure Information

Kim Zuber, PAC, DFAAPA, FNKF

Kim Zuber offers insight into the iatrogenic causes of acute kidney injury. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Reviewed common medications taken by CKD patients, by CKD stage.
  2. Reviewed common dosing errors and the pathological rationale for medication selection, by CKD stage.
  3. Used patient examples, discusses medication dosing errors that are commonly found for the CKD patient.
  4. Provided a quick overview of the OTC meds dangerous for the CKD patient.
  5. Highlighted AKI on CKD for the non-nephrology practitioner.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Don’t miss Kim Zuber sharing her expertise on renal medication dosing as well as CKD and the diabetic kidney at the upcoming 2016 MEDS conference. Click here to learn more.

Kim Zuber offers insight into the iatrogenic causes of acute kidney injury. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Reviewed common medications taken by CKD patients, by CKD stage.
  2. Reviewed common dosing errors and the pathological rationale for medication selection, by CKD stage.
  3. Used patient examples, discusses medication dosing errors that are commonly found for the CKD patient.
  4. Provided a quick overview of the OTC meds dangerous for the CKD patient.
  5. Highlighted AKI on CKD for the non-nephrology practitioner.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

Don’t miss Kim Zuber sharing her expertise on renal medication dosing as well as CKD and the diabetic kidney at the upcoming 2016 MEDS conference. Click here to learn more.

References

References

Publications
Clinician Reviews
Publications
Clinician Reviews
Topics
Nephrology
Endocrinology
Article Type
Video
Display Headline
Renal Medication Dosing: "The Good, the Bad and the Iatrogenic"
Display Headline
Renal Medication Dosing: "The Good, the Bad and the Iatrogenic"
Article Source

PURLs Copyright

Inside the Article

Teaser Media

Understanding the Aging Thyroid

Article Type
Video
Changed
Display Headline
Understanding the Aging Thyroid
Author(s)
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

 

Christine Kessler explains the changes in thyroid hormone levels as we age and provides guidance on how to proceed. This video provides three takeaways in less than three minutes from her presentation the 2015 MEDS conference, entitled “When, Why and How to Treat Hypothyroid Conditions, which

 

  1. Discusses physical assessment and ancillary diagnostic studies to aid in diagnosis & management of hypothyroidism.
  2. Lists common etiologies of hypothyroidism.
  3. Discusses physical assessment and laboratory diagnostic studies to aid in diagnosis & management of hypothyroidism.
  4. Discusses new treatment guidelines in managing gestational hypothyroidism.
  5. Describes how to safely initiate, titrate, monitor and maintain.

 

 

 

 

 

Author and Disclosure Information

 

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

Publications
Clinician Reviews
Topics
Endocrinology
Author(s)
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
Author(s)
Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP
Author and Disclosure Information

 

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

Author and Disclosure Information

 

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

 

Christine Kessler explains the changes in thyroid hormone levels as we age and provides guidance on how to proceed. This video provides three takeaways in less than three minutes from her presentation the 2015 MEDS conference, entitled “When, Why and How to Treat Hypothyroid Conditions, which

 

  1. Discusses physical assessment and ancillary diagnostic studies to aid in diagnosis & management of hypothyroidism.
  2. Lists common etiologies of hypothyroidism.
  3. Discusses physical assessment and laboratory diagnostic studies to aid in diagnosis & management of hypothyroidism.
  4. Discusses new treatment guidelines in managing gestational hypothyroidism.
  5. Describes how to safely initiate, titrate, monitor and maintain.

 

 

 

 

 

 

Christine Kessler explains the changes in thyroid hormone levels as we age and provides guidance on how to proceed. This video provides three takeaways in less than three minutes from her presentation the 2015 MEDS conference, entitled “When, Why and How to Treat Hypothyroid Conditions, which

 

  1. Discusses physical assessment and ancillary diagnostic studies to aid in diagnosis & management of hypothyroidism.
  2. Lists common etiologies of hypothyroidism.
  3. Discusses physical assessment and laboratory diagnostic studies to aid in diagnosis & management of hypothyroidism.
  4. Discusses new treatment guidelines in managing gestational hypothyroidism.
  5. Describes how to safely initiate, titrate, monitor and maintain.

 

 

 

 

 

Publications
Clinician Reviews
Publications
Clinician Reviews
Topics
Endocrinology
Article Type
Video
Display Headline
Understanding the Aging Thyroid
Display Headline
Understanding the Aging Thyroid
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Teaser Media

Type 2 Diabetes in the Pediatric Patient

Article Type
Video
Changed
Display Headline
Type 2 Diabetes in the Pediatric Patient
Author(s)
Donna L. Journsay, CPNP, CDE, CDTC

Donna L. Jornsay identifies the red flags for children at risk for type 2 diabetes and what to do after the diagnosis and why. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Described the pathophysiology of type 2 diabetes in children.
  2. Identified one strategy for decreasing obesity in children.
  3. Stated the number of hours of physical activity needed to prevent pre-diabetes from becoming type 2 diabetes in children.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

You can hear Donna Jornsay present on pediatric type 2 and type 1 diabetes at the upcoming 2016 MEDS conference, where she will incorporate the most up-to-the-minute information available. Click here to learn more.

References

Author and Disclosure Information

Donna L. Jornsay, CPNP, CDE, CDTC

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Pediatrics
Endocrinology
Author(s)
Donna L. Journsay, CPNP, CDE, CDTC
Author(s)
Donna L. Journsay, CPNP, CDE, CDTC
Author and Disclosure Information

Donna L. Jornsay, CPNP, CDE, CDTC

Author and Disclosure Information

Donna L. Jornsay, CPNP, CDE, CDTC

Donna L. Jornsay identifies the red flags for children at risk for type 2 diabetes and what to do after the diagnosis and why. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Described the pathophysiology of type 2 diabetes in children.
  2. Identified one strategy for decreasing obesity in children.
  3. Stated the number of hours of physical activity needed to prevent pre-diabetes from becoming type 2 diabetes in children.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

You can hear Donna Jornsay present on pediatric type 2 and type 1 diabetes at the upcoming 2016 MEDS conference, where she will incorporate the most up-to-the-minute information available. Click here to learn more.

Donna L. Jornsay identifies the red flags for children at risk for type 2 diabetes and what to do after the diagnosis and why. This video provides three takeaways in less than three minutes from her presentation at the 2015 MEDS conference, which

  1. Described the pathophysiology of type 2 diabetes in children.
  2. Identified one strategy for decreasing obesity in children.
  3. Stated the number of hours of physical activity needed to prevent pre-diabetes from becoming type 2 diabetes in children.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

You can hear Donna Jornsay present on pediatric type 2 and type 1 diabetes at the upcoming 2016 MEDS conference, where she will incorporate the most up-to-the-minute information available. Click here to learn more.

References

References

Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Publications
Clinician Reviews
Type 2 Diabetes ICYMI
Topics
Diabetes
Pediatrics
Endocrinology
Article Type
Video
Display Headline
Type 2 Diabetes in the Pediatric Patient
Display Headline
Type 2 Diabetes in the Pediatric Patient
Article Source

PURLs Copyright

Inside the Article

Teaser Media
Subscribe to Video